Search for Clinical Trial Results

Sponsored By

Hereditary Angioedema - 12 Studies Found

Status Study
Completed Study Name: C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Date: 2006-02-07
Interventions:
  • Biological: C1 esterase inhibitor [human] (C1INH-nf)
Completed Study Name: A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor
Condition: Hereditary Angioedema Types I and II
Date: 2012-12-24
Interventions:
  • Biological: Berinert Berinert

Completed Study Name: A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route
Condition: Hereditary Angioedema Types I and II
Date: 2012-04-10
Interventions:
  • Biological: C1-esterase inhibitor - single intravenous dose

Completed Study Name: Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert
Condition: Hereditary Angioedema Types I and II
Date: 2011-11-07
Interventions: Biological: Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection
Completed Study Name: Kinetics, Efficacy and Safety of C1-Esteraseremmer-N
Condition:
  • Hereditary Angioedema Type I
  • Angioneurotic Edema

Date: 2005-07-04
Interventions: Drug: C1 inhibitor concentrate
Completed Study Name: CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Date: 2025-11-04
Interventions: Fully human immunoglobulin G subclass 4/lambda recombinant inhibitor monoclonal antibody administered subcutaneously (SC)
Completed Study Name: A Study of STAR-0215 in Participants With Hereditary Angioedema
Condition: Hereditary Angioedema
Date: 2025-11-04
Interventions: STAR-0215 will be administered as a subcutaneous bolus injection.
COMPLETED Study Name: A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home
Condition: Hereditary Angioedema (HAE)
Date: 2025-11-04
Interventions: No Intervention will be administered in this study.
COMPLETED Study Name: A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II
Condition: Hereditary Angioedema (HAE)
Date: 2025-11-04
COMPLETED Study Name: A Study of STAR-0215 in Participants With Hereditary Angioedema
Condition: Hereditary Angioedema
Date: 2025-11-04
Interventions: STAR-0215 will be administered as a subcutaneous bolus injection.
Next >>>